<DOC>
	<DOCNO>NCT00017108</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . It yet know chlorambucil regimen effective treat advanced chronic lymphocytic leukemia . PURPOSE : Randomized phase III trial determine effectiveness different regimen chlorambucil treat patient advance chronic lymphocytic leukemia .</brief_summary>
	<brief_title>Chlorambucil Treating Patients With Advanced Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall disease-related survival patient B-cell chronic lymphocytic leukemia treat high-dose chlorambucil induction therapy without low-dose chlorambucil maintenance therapy . - Compare time salvage treatment patient treat regimen . - Compare toxic effect regimens patient . - Compare treatment-related mortality patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center , time complete response ( 12 week vs 12 week vs partial response ) , cytopenia diagnosis ( Binet stage A+B v C ) . All patient receive induction therapy comprise high-dose oral chlorambucil daily . Treatment continue achievement complete response maximum 24 week absence disease progression unacceptable toxicity . Patients respond induction therapy randomize 1 2 treatment arm maintenance therapy . - Arm I : Patients receive low-dose oral chlorambucil twice week . Therapy continue 5 year absence disease progression unacceptable toxicity . If disease progression occur , patient may proceed salvage therapy . - Arm II : Patients receive maintenance therapy . If disease progress , patient receive induction therapy . If disease respond re-induction therapy , patient may proceed salvage therapy . - Salvage therapy : Patients progressive disease maintenance therapy receive fludarabine IV daily cyclophosphamide IV daily day 1-3 . Treatment repeat every 4 week 3-6 course . Patients follow monthly 3 month , every 2 month 6 month , every 3 month thereafter . PROJECTED ACCRUAL : Approximately 470 patient accrue study within 4.7 year .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Chlorambucil</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis Bcell chronic lymphocytic leukemia Coexpression CD5/CD19 CD5/CD20 positivity , dim sIg , CD23 positivity Previously untreated advanced disease define presence least 1 follow : Total tumor mass ( TTM ) score great 9 TTM double time le 12 month Bone marrow failure ( platelet count le 100,000/mm^3 and/or hemoglobin le 10 g/dL ) PATIENT CHARACTERISTICS : Age : 18 75 Performance status : WHO 02 Life expectancy : Not specify Hematopoietic : See Disease Characteristics Hepatic : Bilirubin le 3 time upper limit normal ( ULN ) Hepatitis B negative No active hepatitis C Renal : Creatinine le 3 time ULN OR Creatinine clearance great 0.5 time normal Cardiovascular : No severe cardiovascular disease No arrhythmia require chronic treatment No New York Heart Association class III IV congestive heart failure No symptomatic ischemic heart disease Other : No uncontrolled systemic infection HIV negative No prior concurrent uncontrolled malignancy No prior concurrent central nervous system psychiatric disorder require hospitalization No psychological , familial , sociological , geographical condition would preclude study participation PRIOR CONCURRENT THERAPY : Biologic therapy : No prior biologic therapy Chemotherapy : No prior chemotherapy Endocrine therapy : Prior steroid therapy le 2 week allow Radiotherapy : No prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2004</verification_date>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
	<keyword>B-cell chronic lymphocytic leukemia</keyword>
</DOC>